Fulcrum Therapeutics Inc (NAS:FULC)
$ 7.47 -0.03 (-0.4%) Market Cap: 464.29 Mil Enterprise Value: 238.89 Mil PE Ratio: 0 PB Ratio: 1.97 GF Score: 48/100

Q3 2019 Fulcrum Therapeutics Inc Earnings Call Transcript

Nov 14, 2019 / 01:00PM GMT
Release Date Price: $7.64 (-3.29%)
Operator

Good morning, and welcome to the Fulcrum Therapeutics Third Quarter 2019 Conference Call. (Operator Instructions) I would now like to turn the call over to Peter Thomas -- Peter Thomson, Vice President of Finance and Accounting at Fulcrum, please proceed.

Peter G. Thomson
Fulcrum Therapeutics, Inc. - VP of Finance & Accounting

Good morning. Welcome to Fulcrum's Third Quarter 2019 Conference Call. We issued a press release earlier today reviewing our third quarter 2019 results and business updates, which will be covered on this call. A replay of today's call will be available on the Investors and Media section of our website. After our prepared remarks, we will open the call for Q&A.

Before we begin, I'd like to mention that our call will contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans, clinical development time lines and financial projections. I encourage you to review our filings with the Securities and Exchange

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot